XML 26 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured At Fair Value On Recurring Basis
The Company's financial instruments measured at fair value in the accompanying Consolidated Balance Sheets on a recurring basis consist of the following:
 
 
As of
 
As of
 
 
December 31, 2019
 
December 31, 2018
(In thousands)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds (1)
 
$
24,327

 
$
—

 
$
—

 
$
24,327

 
$
6,037

 
$
—

 
$
—

 
$
6,037

Certificates of deposit (2)
 
—

 
1,009

 
—

 
1,009

 
—

 
986

 
—

 
986

Investment in equity securities
 
—

 
—

 
—

 
—

 
6,100

 
—

 
—

 
6,100

Total
 
$
24,327

 
$
1,009

 
$
—

 
$
25,336

 
$
12,137

 
$
986

 
$
—

 
$
13,123

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financing derivatives: no hedging designation (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate reset
 
$
—

 
$
—

 
$
18,800

 
$
18,800

 
$
—

 
$
—

 
$
23,300

 
$
23,300

Make-whole change of control
 
—

 
—

 
1,600

 
1,600

 
—

 
—

 
2,800

 
2,800

Qualifying change of control
 
—

 
—

 
1,187

 
1,187

 
—

 
—

 
—

 
—

Warrants Issued: (4)
 
 
 
 
 
 
 


 
 
 
 
 
 
 


Series A
 
—

 
—

 
7,508

 
7,508

 
—

 
—

 
—

 
—

Series B-2
 
—

 
—

 
217

 
217

 
—

 
—

 
—

 
—

Total
 
$
—

 
$
—

 
$
29,312

 
$
29,312

 
$
—

 
$
—

 
$
26,100

 
$
26,100

(1) Level 1 cash equivalents are invested in money market funds that are intended to maintain a stable net asset value of $1.00 per share by investing in liquid, high quality U.S. Dollar-denominated money market instruments with maturities less than three months.
(2) The Company’s certificates of deposit are recorded at their face value which approximates their fair value.
(3) The fair values of the financing derivatives are derived from techniques which utilize inputs, certain of which are significant and unobservable, that result in classification as Level 3 fair value measurements.
(4) The fair values of the warrant liabilities are derived from techniques which utilize inputs, certain of which are significant and unobservable, that result in classification as Level 3 fair value measurements. The fair value of the Series B-1 warrants was estimated as negligible as of December 31, 2019. The Series B-1 warrants expired without exercise on January 29, 2020.
Schedule of Changes in Level 3 Fair Valued Instruments
The following tables present the changes in the Company's recurring Level 3 fair value measurements for the financing derivatives for the years ended December 31, 2019 and 2018:
(In thousands)
 
Financing Derivative Liabilities
Balance as of December 31, 2017
 
$
—

Issuances
 
17,574

Total losses included in other income (expense), net (1)
 
14,226

Settlement (2)
 
(5,700
)
Balance as of December 31, 2018
 
26,100

Issuances
 
587

Total gain included in other income (expense), net (3)
 
(5,100
)
Balance as of December 31, 2019
 
$
21,587

(1) Represents change in fair value of interest rate reset derivative liability $13.6 million loss, Notes Option derivative liability $3.3 million loss, and change of control derivative liability of $2.7 million gain. All changes in fair value were recorded in other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss.
(2) Represents settlement of the Notes Option derivative liability through the issuance of the Option Notes on May 17, 2018. The derivative was net settled with the Option Notes and recorded as an issuance premium. Refer to Footnote 4, Long-term Debt, for further information.
(3) Represents $4.5 million gain due to change in fair value of interest rate reset derivative liability and $0.6 million gain due to change in fair value of the make-whole redemption derivative liability. All gains were recorded in other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss.
The following tables present the changes in the Company's recurring Level 3 fair value measurements for the warrants liability for the year ended December 31, 2019:
(In thousands)
 
Warrants Liability
Balance as of December 31, 2018
 
$
—

Issuance of warrants liability
 
10,798

Settlement
 
(5,484
)
Total losses included in other income (expense), net (1)
 
2,411

Balance as of December 31, 2019
 
$
7,725

(1) Represents $3.6 million loss due to change in fair value of the Series A Warrants, $0.3 million gain due to change in fair value of the Series B-1 Warrants, $0.2 million gain due to change in fair value of the Series B-2 Warrants, and $0.7 million gain due to change in fair value of Series C Warrants. All gains and losses were recorded in other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss.
Schedule of Valuation Techniques And Unobservable Inputs For Level 3 Liabilities
The following table displays valuation techniques and the significant inputs, certain of which are unobservable, for the Company's Level 3 liabilities measured at fair value as of December 31, 2019 and 2018:
 
Fair value measurements
 
Significant valuation technique
 
Significant valuation inputs
 
December 31, 2019
 
December 31, 2018
Interest rate reset derivative liability
Discounted cash flow
 
Discount rate
 
25.0%
 
25.0%
 
 
 
Stock price
 
$4.94
 
$14.43
 
 
 
Volatility
 
74.1%
 
43.9%
 
 
 
Term
 
2.04 years
 
3.04 years
 
 
 
Risk-free rate
 
1.6%
 
2.5%
 
 
 
 
 
 
 
 
Make-whole change of control redemption derivative liability
Option pricing model
 
Change of control probability
 
5.0 - 10.0%
 
0.0 - 10.0%
 
 
 
Term
 
2.04 years
 
3.04 years
 
 
 
Risk-free rate
 
1.6%
 
2.5%
 
 
 
 
 
 
 
 
Qualifying change of control redemption derivative liability
Discounted cash flow
 
Change of control probability
 
5.0%
 
 
 
 
 
Term
 
0.60 years
 
 
 
 
 
Discount rate
 
25.0%
 
 
 
 
 
 
 
 
 
 
Warrants liability(1)
Option pricing model
 
Stock price
 
$4.94
 
 
 
 
 
Volatility
 
65.0%
 
 
 
 
 
Term
 
0.59 - 4.49 years
 
 
 
 
 
Change of control probability
 
5.0 - 10.0%
 
 
 
 
 
Risk-free rate
 
1.6 - 1.7%
 
 
 
 
 
Cost of debt
 
14.7 - 16.0%
 
 
(1) Warrants liability includes Series A and Series B-2.